Prevenar 20, Injektionssuspension in einer Fertigspritze

7680692220028 CH-69222 Injektionssuspension
Prevenar 20, Injektionssuspension in einer Fertigspritze
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/04/2026
Summary of Product Characteristics
Français
22/04/2026
Summary of Product Characteristics
Italien
22/04/2026

Detailed composition

Substance Quantity Type Category
polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.4 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 15B conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida
46.2 UG Substance WIIS
proteinum corynebacteriae diphtheriae CRM 197
51.0 UG Substance WIIS
aluminium
0.125 MG Substance HIMDK
aluminii phosphas
- Substance HNIDK
acidum succinicum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
1.73 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 660.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69222
Drug name
Prevenar 20, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07AL02
Authorization status
Z
Dispensing category
B
First authorization
26/03/2024
Authorization expiration date
25/03/2029
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen der Serotypen 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F

Package details

Description (FR)
PREVENAR 20 susp inj 10 ser pré 0.5 ml
Description (DE)
PREVENAR 20 Inj Susp 10 Fertspr 0.5 ml
Market launch
26/03/2024
Narcotic (BTM)
No

Other package sizes (1)

PREVENAR 20 susp inj ser pré 0.5 ml
1 FESP
GTIN: 7680692220011
View
Buy us a coffee Explore the data